Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT NO. 1 TO CURRENT REPORT - OptimizeRx Corp | f8k100419a1_optimizerxcorp.htm |
| EX-99.3 - OptimizeRx Corp | f8k100419a1ex99-3_optimizerx.htm |
| EX-99.2 - UNAUDITED FINANCIAL STATEMENTS FOR RMDY - OptimizeRx Corp | f8k100419a1ex99-2_optimizerx.htm |
| EX-99.1 - AUDITED FINANCIAL STATEMENTS FOR RMDY - OptimizeRx Corp | f8k100419a1ex99-1_optimizerx.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 No. 333-228357 and Form S-8 No. 333-210653 of OptimizeRx Corp. of our report dated December 18, 2019 relating to the financial statements of RMDY Health Inc., which appears in this Current Report on Form 8-K/A.
| Tel-Aviv, Israel | /s/ Kesselman & Kesselman | |||
| December 18, 2019 |
Certified Public Accountants (Isr.) A member firm of PricewaterhouseCoopers International Limited | |||